| William Pirate Madsen, RPH | |
|
3475 E 17th St, Ammon, ID 83406-6781 | |
| (208) 227-5083 | |
| (208) 227-5087 |
| Full Name | William Pirate Madsen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3475 E 17th St, Ammon, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033309935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P4168 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Pirate Madsen, RPH 3475 E 17th St, Ammon, ID 83406-6781 Ph: (208) 227-5083 | William Pirate Madsen, RPH 3475 E 17th St, Ammon, ID 83406-6781 Ph: (208) 227-5083 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Finding ways to end elder abuse is the theme of a free seminar sponsored by the Congress of California Seniors Region 3. The event will be held from 11:30 a.m.-2 p.m. on Thursday, May 17, 2012 at the St. Regis Retirement Center, 23950 Mission Blvd., in Hayward.
Calcium antagonists such as nifedipine are used to relieve the symptoms of angina, but there have been doubts about their long-term safety. However, ACTION-A Coronary disease Trial Investigating Outcome with Nifedipine GITS-provides new information on the drug's long-term use. GITS (gastrointestinal therapeutic system) modifies the release of the drug to provide stable long-term concentrations of nifedipine in blood.
BerGenBio AS, an oncology biopharmaceutical company, today announces that an abstract on the latest data on BGB324, the Company's first-in-class, selective small molecule inhibitor of the Axl receptor tyrosine kinase, and BGB10C9, an Axl function-blocking monoclonal antibody in pre-clinical development at BerGenBio, has been published in conjunction with the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29 - June 2, 2015.
› Verified 9 days ago
Bruce Webb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3250 E 17th St, Ammon, ID 83406 Phone: 208-552-7677 Fax: 208-552-2098 | |
Jacee Clark, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3160 E 17th St Ste 164, Ammon, ID 83406 Phone: 208-529-1795 | |
Lance Denning, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 E Sunnyside Rd, Ammon, ID 83406 Phone: 208-522-3257 | |
Spencer Louis Dietz, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3250 E 17th St, Ammon, ID 83406 Phone: 208-552-7677 | |
Dorothy Elaine Roberts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3101 E 17th St, Ammon, ID 83406 Phone: 208-522-4824 Fax: 208-523-6830 | |
Tarmigan Cushing, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 S 25th E, Ammon, ID 83406 Phone: 208-522-2866 |